Intervention
folic acid
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 5 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
5 shownSingle Ascending Dose Study of Safety and Tolerability of Sarilumab and Methotrexate in Japanese Patients With Rheumatoid ArthritisNCT01850680 · 2013-04-01
COMPLETEDEvaluation of Mirtazapine and Folic Acid for Schizophrenia:NCT01263080 · 2010-11-01
COMPLETEDBrodalumab (AMG 827) in Rheumatoid Arthritis (RA) Participants With Inadequate Response to MethotrexateNCT00950989 · 2009-12-30
COMPLETEDA Study of Subcutaneously Administered Tocilizumab in Patients With Rheumatoid ArthritisNCT00965653 · 2009-08-01
COMPLETEDLometrexol Plus Folic Acid in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerNCT00033722 · 2002-02-01
UNKNOWNCommon conditions
Leading sponsors
Trial status mix
COMPLETED4
UNKNOWN1
Phase mix
PHASE12
PHASE22
PHASE41
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.